We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, inc... Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer. Show more
- Enrollment continued on target in EMERALD-2 Phase 2b trial of MORF-057 in ulcerative colitis- -Appointed Dr. Simon Cooper as Chief Medical Officer- -Anticipate dosing first patient in GARNET...
WALTHAM, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of...
WALTHAM, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious...
-Reported positive results from EMERALD-1 phase 2a trial of MORF-057 in ulcerative colitis (UC)- -Enrollment on target in EMERALD-2 phase 2b global randomized trial of MORF-057 in UC- -GARNET...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.12 | 0.438116100767 | 27.39 | 29.59 | 26.36 | 473140 | 28.18831277 | CS |
| 4 | -7.53 | -21.4897260274 | 35.04 | 35.56 | 26.36 | 429655 | 29.41506517 | CS |
| 12 | -6.63 | -19.4200351494 | 34.14 | 41.47 | 26.36 | 485691 | 34.30568349 | CS |
| 26 | 7.39 | 36.7296222664 | 20.12 | 41.47 | 19.345 | 533782 | 29.78872733 | CS |
| 52 | -20.38 | -42.5558571727 | 47.89 | 63.0825 | 19.345 | 666062 | 35.40184194 | CS |
| 156 | -27.75 | -50.217155266 | 55.26 | 68.75 | 19.23 | 413201 | 36.68071307 | CS |
| 260 | 9.51 | 52.8333333333 | 18 | 93 | 9.9 | 305734 | 37.85877309 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
